235 related articles for article (PubMed ID: 994219)
21. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
22. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
Fisher B; Wolmark N; Rubin H
J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
[TBL] [Abstract][Full Text] [Related]
23. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
24. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours.
Likhite VV
Nature; 1976 Feb; 259(5542):397-9. PubMed ID: 1250378
[No Abstract] [Full Text] [Related]
26. The delayed rejection of tumors formed from the administration of tumor cells mixed with killed Corynebacterium parvum.
Likhite VV; Halpern BN
Int J Cancer; 1973 Nov; 12(3):699-704. PubMed ID: 4524799
[No Abstract] [Full Text] [Related]
27. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
28. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
Woodruff MF; Warner NL
J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
[TBL] [Abstract][Full Text] [Related]
29. Rejection of mammary adenocarcinoma cell tumors and the prevention of progressive growth of incipient metastases following intratumor permeation with killed Bordetella pertussis.
Likhite VV
Cancer Res; 1974 Oct; 34(10):2790-4. PubMed ID: 4370327
[No Abstract] [Full Text] [Related]
30. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
Mazurek C; Chalvet H; Stiffel CL; Biozzi G
Int J Cancer; 1976 Apr; 17(4):511-7. PubMed ID: 946965
[TBL] [Abstract][Full Text] [Related]
31. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
Woodruff MF; Inchley MP; Dunbar N
Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
[TBL] [Abstract][Full Text] [Related]
32. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
Stiffel C; Chalvet H; Mazurek C
Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of purified cell walls from Corynebacterium parvum.
Riveros-Moreno V; Bomford R; Scott MT
J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
[TBL] [Abstract][Full Text] [Related]
35. C. parvum treatment of transplanted rat tumours of spontaneous origin.
Willmott N; Pimm MV; Baldwin RW
Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
[TBL] [Abstract][Full Text] [Related]
36. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
38. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
[No Abstract] [Full Text] [Related]
39. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
Dye ES; North RJ; Mills CD
J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
[TBL] [Abstract][Full Text] [Related]
40. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]